Abstract
Percutaneous coronary intervention (PCI) is not associated with reduction in risk of death or myocardial infarction in patients who have chronic stable angina with normal left ventricular function and moderate coronary artery disease. A substudy of the COURAGE trial has shown that both PCI plus optimal medical therapy (OMT) and OMT alone result in marked improvements in quality of life and angina, but that PCI can substantially benefit patients with more-severe and more-frequent angina. A number of caveats to this study exist, including the extent to which the findings can be applied to the general patient population and the large proportion of patients who had mild angina or were asymptomatic—it is difficult to make these patients feel better. In addition, the remarkable commitment of both healthcare providers and patients in this study would be hard to achieve in clinical practice. Nevertheless, for patients with mild or no angina and no significant ischemia on stress testing, the COURAGE trial reassures us that OMT alone can be efficacious in reducing angina and/or improving quality of life.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Boden WE et al. (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503–1516
King SB (2007) The COURAGE trial: is there still a role for PCI in stable coronary artery disease? Nat Clin Pract Cardiovasc Med 4: 410–411
Shaw LJ et al. (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 117: 1283–1291
Weintraub WS et al. (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359: 677–687
Kirtane AJ and Cohen DJ (2008) When is better not good enough? Insights from the COURAGE economic study. Circ Cardiovasc Qual Outcomes 1: 4–6
Peterson ED and Rumsfeld JS (2008) Finding the courage to reconsider medical therapy for stable angina. N Engl J Med 359: 751–753
Weintraub WS et al. on Behalf of the Department of Veterans Affairs Co (2008) Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes 1: 12–20
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Latib, A., Chieffo, A. & Colombo, A. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina. Nat Rev Cardiol 6, 92–93 (2009). https://doi.org/10.1038/ncpcardio1422
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1422